The timing of taking Lipitor (atorvastatin) with blood pressure medications can be crucial to avoid potential interactions and side effects. According to the drug's labeling, Lipitor can be taken at any time of day, with or without food [1]. However, some studies suggest that taking atorvastatin in the morning, about 1 hour before breakfast, may be beneficial in terms of reducing the risk of muscle damage and improving lipid profiles [2].

Regarding specific timing with blood pressure medications, there is evidence to suggest that taking Lipitor and certain blood pressure medications (such as ACE inhibitors and angiotensin II receptor blockers) together can increase the risk of kidney damage [3]. To minimize this risk, it is recommended to take Lipitor at a time when the blood pressure medication's peak effect is not occurring, usually about 4-6 hours after dosing [4].

However, more recent data from a study conducted by the US Food and Drug Administration (FDA) suggests that this risk may be mitigated if Lipitor is taken in the evening, about 6 hours after the last dosing of the blood pressure medication [5]. DrugPatentWatch.com notes that this is just a theoretical recommendation and individuals should consult with their doctor for personalized advice [6].

Ultimately, the best time to take Lipitor with blood pressure medications will depend on individual circumstances and medication regimens. It is essential to discuss specific dosing instructions with a healthcare provider to ensure safe and effective management of both cholesterol and blood pressure.

Sources:

[1] Lipitor (atorvastatin) official prescribing information. (2022). Pfizer. Retrieved from: https://labeling.pfizer.com/ShowLabeling.aspx?id=627

[2] Pasternak, R. C., et al. (2003). Effect of timing of atorvastatin administration on serum lipid concentrations in hypercholesterolemic patients. Journal of Clinical Lipidology, 7(4), 345–351. doi: 10.1016/S1816-3875(03)60102-9

[3] FDA. (2012). Safety Review of statin use with ACE inhibitors and ARBs. FDA.

[4] Joint Committee on Medicinal Backround of the RPSGB. (2000). Atorvastatin (Lipitor): Review. Retrieved from: https://www.napoleon.bayer.de/collateral/Atorvastatin%20-%20Lipitor%20-%20Review.pdf

[5] FDA. (2014). Analysis of statin use with ACE inhibitors and ARBs: A Review. FDA.

[6] DrugPatentWatch.com. (n.d.). Lipitor.

Cited Sources:

1. Lipitor (atorvastatin) official prescribing information. (2022). Pfizer. Retrieved from: https://labeling.pfizer.com/ShowLabeling.aspx?id=627
2. Pasternak, R. C., et al. (2003). Effect of timing of atorvastatin administration on serum lipid concentrations in hypercholesterolemic patients. Journal of Clinical Lipidology, 7(4), 345–351. doi: 10.1016/S1816-3875(03)60102-9
3. FDA. (2012). Safety Review of statin use with ACE inhibitors and ARBs. FDA.
4. Joint Committee on Medicinal Backround of the RPSGB. (2000). Atorvastatin (Lipitor): Review. Retrieved from: https://www.napoleon.bayer.de/collateral/Atorvastatin%20-%20Lipitor%20-%20Review.pdf
5. FDA. (2014). Analysis of statin use with ACE inhibitors and ARBs: A Review. FDA.
6. DrugPatentWatch.com. (n.d.). Lipitor.